NUVB
Nuvation Bio Inc.stockNYSE
At CloseNov 18, 2026 3:59:56 PM EST
3.77USD-3.333%(-0.13)5,957,153
Pre-marketNov 18, 2026 8:42:30 AM EST
3.90USD0.000%(0.00)
After-hoursNov 18, 2026 4:21:30 PM EST
3.7891USD+0.507%(+0.0191)
NUVB News
Nuvation Bio reports updated Phase II J201 data for safusidenib ·
Clinical Trials Arena
Nuvation Bio stock hits 52-week low at 3.91 USD ·
Investing.com
Nuvation Bio presents long-term data on brain cancer drug ·
Investing.com
Nuvation Bio stock hits 52-week low at 4.04 USD ·
Investing.com
Nuvation Bio (NUVB) Q3 2026 Earnings Call Transcript ·
The Motley Fool
Nuvation Bio Inc. (NUVB) Q3 2026 Earnings Call Transcript ·
Seeking Alpha
Nuvation Bio to broaden Phase III glioma trial into Europe ·
Clinical Trials Arena